<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the leading causes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> morbidity and mortality in Western countries </plain></SENT>
<SENT sid="1" pm="."><plain>One of the risk factors for colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> is <z:chebi fb="27" ids="27300">vitamin D</z:chebi> insufficiency </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to establish whether increasing dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> intake can prevent or delay development of chemically induced <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> in the colon of mice </plain></SENT>
<SENT sid="3" pm="."><plain>We fed six weeks old female C57BL/6J mice (n=28) with increasing <z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3) concentrations (100, 400, 1000, 2500, 5000IU/kg diet) </plain></SENT>
<SENT sid="4" pm="."><plain>To induce <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, a preneoplastic lesion, we injected mice with the carcinogen azoxymethane (10mg/kg) intraperitoneally, followed by three cycles of 2% <z:chebi fb="0" ids="52071">dextran</z:chebi> <z:chebi fb="0" ids="32149">sodium sulfate</z:chebi> salt, a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter, in the drinking water </plain></SENT>
<SENT sid="5" pm="."><plain>To test our hypothesis that high <z:chebi fb="27" ids="27300">vitamin D</z:chebi> intake prevents formation of <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath>, we have investigated the effect of increasing dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> on development of premalignant colorectal lesions, serum 25-hydroxyvitamin D(3) (25-D(3)) levels, and expression of renal <z:chebi fb="27" ids="27300">vitamin D</z:chebi> system genes </plain></SENT>
<SENT sid="6" pm="."><plain>Dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> concentration correlated inversely with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> score (Spearman's correlation coefficient, ρ: -0.579, p=0.002) and positively with serum 25-D(3) levels (ρ: 0.752, p=0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Increasing dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> concentration beyond 1000IU/kg led to no further increase in circulating 25-D(3) levels, while the <z:mpath ids='MPATH_589'>dysplasia</z:mpath> score leveled out at ≥2500IU/kg <z:chebi fb="27" ids="27300">vitamin D</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>High dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> intake led to increased renal <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of the <z:chebi fb="27" ids="27300">vitamin D</z:chebi> catabolizing enzyme cyp24a1 (ρ: 0.518, p=0.005) and decreased expression of the <z:chebi fb="27" ids="27300">vitamin D</z:chebi> activating enzyme cyp27b1 (ρ: -0.452, p=0.016), protecting the body from toxic serum levels of the active <z:chebi fb="27" ids="27300">vitamin D</z:chebi> metabolite 1,25-dihydroxyvitamin D(3) (1,25-D(3)) </plain></SENT>
<SENT sid="9" pm="."><plain>Our data showed that increasing dietary <z:chebi fb="27" ids="27300">vitamin D</z:chebi> intake is able to prevent chemically induced <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>The maximum impact was achieved when the mice consumed more than 2500IU <z:chebi fb="27" ids="27300">vitamin D</z:chebi>/kg diet </plain></SENT>
<SENT sid="11" pm="."><plain>This article is part of a Special Issue entitled '<z:chebi fb="27" ids="27300">Vitamin D</z:chebi> Workshop' </plain></SENT>
</text></document>